ACHIA

2007 Presentations


Wednesday, February 21, 2007

"Quantitative Studies of Cytomegalovirus"
Speaker: Paul Griffiths, MD

Thursday, February 22, 2007

"Welcome"
Speaker: Richard Whitley, MD

"This year in review"
Speaker:  Walla Dempsey


"CASG 103/104/106"
Speaker: David Kimberlin, MD

"CASG 210/211"
Speakers: John Gnann, MD and Amy Agrawal, MD

"Herpes Infections of Transplant Recipients"
Speaker: Michael Boeckh, MD

 

"Antiviral Drugs in Development-HHV6"
Speaker:  Earl Kern, Ph.D.

 

"Development of SCY-635 - a potent inhibitor of cyclophilin B"
Speaker:  Sam Hopkins, Ph.D.

"CASG 113/114"
Speaker: David Kimberlin, MD


 

"PI Responsibilities in FDA Audit"
Speaker: Kim Havens.



"Monkey Pox"
Speaker: Anne Rimoin, Ph.D.

"BK CASG 209"
Speaker:  Ajit Limaye, MD
       

              

"Current Status of Lipophilic Cidofovir Research"
Speaker: Wendy Painter, MD
    

        

 "Update on Maribavir"
Speaker:  Steve Villano, MD
                     

"CASG 109/112"
Speaker:  David Kimberlin, MD
  

               

Breakout Sessions 

"New Therapies in Hepatitis B"
Speaker:  Richard Pollard, MD

                                   
"CASG 109/112 - Pediatric CMV"
Speaker: David Kimberlin, MD
        

                 

"CASG 209 BK Virus"
Speakers:  John Gnann, MD and Ajit Limaye, MD

Friday, February 23, 2007

"Herpes Infection of the Brain"
Speaker: Birgit Skoldenberg, MD       


"CASG 204"
John Gnann, MD


"Peramivir"
Jim Alexander, MD, MPH
                                

Breakout Sessions

"CASG 204 HSE"
John Gnann, MD/F.Y. Aoki, MD
 

                
 "CASG 103/104/106/114"
 David Kimberlin, MD